Klinikmanual page visits letzter Monat
Es wurden 11781 Seitenzugriffe registriert.
prev next
| ID | Datum | Zeit | Kapitel | Artikel |
|---|---|---|---|---|
| 2538768 | 12.11.2025 | 20:55:28 | benign_disease | Parasitäre Lebererkrankungen |
| 2538769 | 12.11.2025 | 20:55:32 | memo | AO Klassifikation der Frakturen |
| 2538770 | 12.11.2025 | 20:55:43 | benign_disease | Milzruptur: Behandlungsrichtlini |
| 2538771 | 12.11.2025 | 20:55:46 | memo | Kompartmentsyndrom |
| 2538772 | 12.11.2025 | 20:55:59 | benign_disease | Cholezystitis und Cholezystolith |
| 2538773 | 12.11.2025 | 20:55:59 | memo | Parathomonbestimmung intraoperat |
| 2538774 | 12.11.2025 | 20:56:11 | memo | Hypokalzämie nach operativen Ein |
| 2538775 | 12.11.2025 | 20:56:13 | benign_disease | Akutes Abdomen: Behandlungsricht |
| 2538776 | 12.11.2025 | 20:56:23 | memo | Aufklärung, wichtige Dokumentati |
| 2538777 | 12.11.2025 | 20:56:27 | benign_disease | GI-Blutungen: Behandlungsrichtli |
| 2538778 | 12.11.2025 | 20:56:35 | memo | Koronarstents: Management von Pa |
| 2538779 | 12.11.2025 | 20:56:41 | benign_disease | Magen- und Duodenalulkus |
| 2538780 | 12.11.2025 | 20:56:48 | memo | Untersuchungen mit Röntgenkontra |
| 2538781 | 12.11.2025 | 20:56:55 | benign_disease | Gastroösophageale Refluxkrankhei |
| 2538782 | 12.11.2025 | 20:57:01 | malignant_disease | Rektumkarzinom |
| 2538783 | 12.11.2025 | 21:57:07 | benign_disease | Gastroösophageale Refluxkrankhei |
| 2538784 | 12.11.2025 | 20:57:07 | benign_disease | Ösophagusdivertikel |
| 2538785 | 12.11.2025 | 20:57:14 | malignant_disease | Kolonkarzinom |
| 2538786 | 12.11.2025 | 20:57:20 | benign_disease | Ösophagusmotilitätsstörungen |
| 2538787 | 12.11.2025 | 20:57:26 | malignant_disease | Gastrointestinale Lymphome |
| 2538788 | 12.11.2025 | 20:57:37 | malignant_disease | Maligne Tumoren der Leber |
| 2538789 | 12.11.2025 | 20:57:46 | allgemein | Malignes Melanom |
| 2538790 | 12.11.2025 | 20:57:49 | malignant_disease | Gallenwegs- und Gallenblasenkarz |
| 2538791 | 12.11.2025 | 20:58:02 | malignant_disease | Pankreaskarzinom |
| 2538792 | 12.11.2025 | 20:58:13 | malignant_disease | Gastrointestinale Stromatumore ( |
| 2538793 | 12.11.2025 | 20:58:25 | malignant_disease | Magenkarzinom |
| 2538794 | 12.11.2025 | 20:58:36 | malignant_disease | Analkarzinom |
| 2538795 | 12.11.2025 | 20:58:48 | malignant_disease | Ösophaguskarzinom |
| 2538796 | 12.11.2025 | 20:59:14 | history | Facts aus der Geschichte der Chi |
| 2538797 | 12.11.2025 | 20:59:25 | flowchart | Safety Checklist WHO |
| 2538798 | 12.11.2025 | 20:59:35 | flowchart | Flowchart Sigmadivertikulitis |
| 2538799 | 12.11.2025 | 20:59:46 | flowchart | Flowchart Rektumkarzinom |
| 2538800 | 12.11.2025 | 20:59:58 | flowchart | Flowchart Kolonkarzinom |
| 2538801 | 12.11.2025 | 21:00:07 | flowchart | Flowchart Plattenepithelkarzinom |
| 2538802 | 12.11.2025 | 21:00:12 | Home | |
| 2538803 | 12.11.2025 | 21:00:19 | flowchart | Flowchart Adenokarzinom des Ösop |
| 2538804 | 12.11.2025 | 21:00:24 | definition | Variable |
| 2538805 | 12.11.2025 | 21:00:30 | flowchart | Flowchart Magenkarzinom |
| 2538806 | 12.11.2025 | 21:00:36 | definition | Retrospektive Erhebung |
| 2538807 | 12.11.2025 | 21:00:42 | endocrine_disease | Nebennierentumor |
| 2538808 | 12.11.2025 | 21:00:47 | definition | Randomisierte Studie |
| 2538809 | 12.11.2025 | 21:00:53 | endocrine_disease | Endokrine Tumore des GI-Traktes |
| 2538810 | 12.11.2025 | 21:01:00 | definition | Sensitivität |
| 2538811 | 12.11.2025 | 21:01:03 | endocrine_disease | Karzinoidtumor (NET) |
| 2538812 | 12.11.2025 | 21:01:11 | definition | Spezifität |
| 2538813 | 12.11.2025 | 21:01:15 | endocrine_disease | Gastrinom |
| 2538814 | 12.11.2025 | 21:01:23 | definition | Prospektive Erhebung |
| 2538815 | 12.11.2025 | 21:01:26 | endocrine_disease | Schilddrüsenmalignom |
| 2538816 | 12.11.2025 | 21:01:34 | definition | Prävalenz |
| 2538817 | 12.11.2025 | 21:01:37 | endocrine_disease | Nebenschilddrüse |
| 2538818 | 12.11.2025 | 21:01:46 | definition | Phase IV Studie |
| 2538819 | 12.11.2025 | 21:01:47 | endocrine_disease | Benigne Schilddrüsenerkrankungen |
| 2538820 | 12.11.2025 | 21:01:59 | definition | Phase III Studie |
| 2538821 | 12.11.2025 | 21:02:09 | definition | Phase II Studie |
| 2538822 | 12.11.2025 | 21:02:11 | definition | Variable |
| 2538823 | 12.11.2025 | 21:02:22 | malignant_disease | Rektumkarzinom |
| 2538824 | 12.11.2025 | 21:02:22 | definition | Retrospektive Erhebung |
| 2538825 | 12.11.2025 | 21:02:33 | definition | Phase I Studie |
| 2538826 | 12.11.2025 | 21:02:33 | definition | Randomisierte Studie |
| 2538827 | 12.11.2025 | 21:02:45 | definition | Sensitivität |
| 2538828 | 12.11.2025 | 21:02:45 | definition | Parameter |
| 2538829 | 12.11.2025 | 21:02:56 | definition | Spezifität |
| 2538830 | 12.11.2025 | 21:02:57 | definition | Morbidität |
| 2538831 | 12.11.2025 | 21:03:07 | definition | Prospektive Erhebung |
| 2538832 | 12.11.2025 | 21:03:08 | definition | Mortalität |
| 2538833 | 12.11.2025 | 21:03:17 | definition | Prävalenz |
| 2538834 | 12.11.2025 | 21:03:20 | definition | Letalität |
| 2538835 | 12.11.2025 | 21:03:28 | definition | Phase IV Studie |
| 2538836 | 12.11.2025 | 21:03:31 | definition | Leitlinien |
| 2538837 | 12.11.2025 | 21:03:40 | definition | Phase III Studie |
| 2538838 | 12.11.2025 | 21:03:44 | definition | Inzidenz |
| 2538839 | 12.11.2025 | 21:03:51 | definition | Phase II Studie |
| 2538840 | 12.11.2025 | 21:03:54 | definition | Evidenzgrade |
| 2538841 | 12.11.2025 | 21:04:01 | definition | Phase I Studie |
| 2538842 | 12.11.2025 | 21:04:06 | definition | VEGF |
| 2538843 | 12.11.2025 | 21:04:12 | definition | Parameter |
| 2538844 | 12.11.2025 | 21:04:17 | definition | Tumor |
| 2538845 | 12.11.2025 | 21:04:24 | definition | Morbidität |
| 2538846 | 12.11.2025 | 21:04:30 | malignant_disease | Kolonkarzinom |
| 2538847 | 12.11.2025 | 21:04:35 | definition | Mortalität |
| 2538848 | 12.11.2025 | 21:04:40 | definition | TNM |
| 2538849 | 12.11.2025 | 21:04:45 | definition | Letalität |
| 2538850 | 12.11.2025 | 21:04:52 | definition | Schmerzklassifikation |
| 2538851 | 12.11.2025 | 21:04:56 | definition | Leitlinien |
| 2538852 | 12.11.2025 | 21:05:03 | definition | R-Klassifikation |
| 2538853 | 12.11.2025 | 21:05:06 | definition | Inzidenz |
| 2538854 | 12.11.2025 | 21:05:16 | definition | Progression |
| 2538855 | 12.11.2025 | 21:05:19 | definition | Evidenzgrade |
| 2538856 | 12.11.2025 | 21:05:28 | definition | Positronen-Emissions-Tomographie |
| 2538857 | 12.11.2025 | 21:05:32 | definition | VEGF |
| 2538858 | 12.11.2025 | 21:05:39 | definition | Neoadjuvant |
| 2538859 | 12.11.2025 | 21:05:42 | definition | Tumor |
| 2538860 | 12.11.2025 | 21:05:52 | definition | Lymphknotenminima |
| 2538861 | 12.11.2025 | 21:05:53 | definition | TNM |
| 2538862 | 12.11.2025 | 21:06:03 | definition | Karnofsky Index |
| 2538863 | 12.11.2025 | 21:06:06 | definition | Schmerzklassifikation |
| 2538864 | 12.11.2025 | 21:06:14 | definition | Her2 |
| 2538865 | 12.11.2025 | 21:06:16 | definition | R-Klassifikation |
| 2538866 | 12.11.2025 | 21:06:25 | definition | Grading |
| 2538867 | 12.11.2025 | 21:06:28 | definition | Progression |
Normal end of query.
All data (c) 2016 by Scientific Networks, Munich. Data from this source may not be published elsewhere without permission.